← brief for 2026-10-19 · Slowing decline

Retinal Disease Risk With Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors Versus Long-Acting Erythropoiesis-Stimulating Agents in Patients With Non-Dialysis Chronic Kidney Disease: A Real-World Database Analysis in Japan.

Article C Peer reviewed Observational

Key takeaways

This study looked at records of people in Japan with kidney disease who took new oral anemia drugs. It compared them to people who took older anemia shots. It shows a link between the drugs and eye disease, but it is not proof of cause.

Who did this work

Hoshino K · Sasabuchi Y · Miyamoto Y · Hashimoto Y · Yasunaga H

Source

Article · PubMed, CKD progression and prevention · 2026 Oct
https://pubmed.ncbi.nlm.nih.gov/42893965/